Ionescu Rodica Elena
Light, Nanomaterials and Nanotechnology (L2n) Laboratory, CNRS EMR 7004, University of Technology of Troyes, 12 Rue Marie Curie CS 42060, 10004 Troyes, France.
Micromachines (Basel). 2023 Jul 25;14(8):1486. doi: 10.3390/mi14081486.
Nanobodies (Nbs) are known as camelid single-domain fragments or variable heavy chain antibodies (VHH) that in vitro recognize the antigens (Ag) similar to full-size antibodies (Abs) and in vivo allow immunoreactions with biomolecule cavities inaccessible to conventional Abs. Currently, Nbs are widely used for clinical treatments due to their remarkably improved performance, ease of production, thermal robustness, superior physical and chemical properties. Interestingly, Nbs are also very promising bioreceptors for future rapid and portable immunoassays, compared to those using unstable full-size antibodies. For all these reasons, Nbs are excellent candidates in ecological risk assessments and advanced medicine, enabling the development of ultrasensitive biosensing platforms. In this review, immobilization strategies of Nbs on conductive supports for enhanced electrochemical immune detection of food contaminants (Fcont) and human biomarkers (Hbio) are discussed. In the case of Fcont, the direct competitive immunoassay detection using coating antigen solid surface is the most commonly used approach for efficient Nbs capture which was characterized with cyclic voltammetry (CV) and differential pulse voltammetry (DPV) when the signal decays for increasing concentrations of free antigen prepared in aqueous solutions. In contrast, for the Hbio investigations on thiolated gold electrodes, increases in amperometric and electrochemical impedance spectroscopy (EIS) signals were recorded, with increases in the antigen concentrations prepared in PBS or spiked real human samples.
纳米抗体(Nbs)被称为骆驼科动物的单域片段或可变重链抗体(VHH),它们在体外能够识别与全尺寸抗体(Abs)类似的抗原(Ag),在体内则能与传统抗体无法触及的生物分子腔进行免疫反应。目前,纳米抗体因其显著提高的性能、易于生产、热稳定性、优异的物理和化学性质而被广泛应用于临床治疗。有趣的是,与使用不稳定的全尺寸抗体的免疫分析相比,纳米抗体也是未来快速便携免疫分析非常有前景的生物受体。基于所有这些原因,纳米抗体是生态风险评估和先进医学领域的优秀候选者,能够推动超灵敏生物传感平台的发展。在这篇综述中,讨论了将纳米抗体固定在导电载体上以增强对食品污染物(Fcont)和人类生物标志物(Hbio)的电化学免疫检测的策略。对于食品污染物,使用包被抗原固体表面的直接竞争免疫分析检测是最常用的有效捕获纳米抗体的方法,当在水溶液中制备的游离抗原浓度增加导致信号衰减时,用循环伏安法(CV)和差分脉冲伏安法(DPV)对其进行表征。相比之下,对于在硫醇化金电极上进行的人类生物标志物研究,当在磷酸盐缓冲液(PBS)中制备的抗原浓度增加或在真实人类样本中加标时,记录到安培法和电化学阻抗谱(EIS)信号增加。